Reference
Wang F, et al. Effectiveness of osimertinib plus chemotherapy and avastin for untreated EGFR-mutated advanced non-small cell lung cancer. Journal of Clinical Oncology 39 (Suppl.): abstr. e21178, No. 15, 2021. Available from: URL: http://doi.org/10.1200/JCO.2021.39.15_suppl.e21178 [abstract]
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1869, 37 (2021). https://doi.org/10.1007/s40278-021-00902-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-00902-4